Emilio Emini Is The Key To Wyeth Vaccines

In touting the $68 billion proposed deal for Wyeth, Pfizer CEO Jeff Kindler repeatedly cited Wyeth's vaccine business as a key part of the deal. But what exactly will Pfizer get after scooping up this unit? Two crucial assets - one is a product and the other is a person